Prognostic value of PD-L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer

被引:3
|
作者
Zou, Yunlian [1 ,2 ]
Wang, Jinli [2 ,3 ]
Zhang, Jinping [1 ,2 ]
Guo, Qiang [2 ,3 ]
Song, Zhengji [2 ,3 ,4 ]
Tang, Hui [2 ,3 ,4 ]
机构
[1] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Hematol, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Univ Sci & Technol, Med Fac, Kunming 650504, Yunnan, Peoples R China
[3] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Gastroenterol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
[4] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Gastroenterol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; multiplex immunohistochemistry; programmed death receptor ligand 1; cluster of differentiation 68; prognosis biomarker; DEATH-LIGAND; 1; INFILTRATING LYMPHOCYTES; SIGNIFICANT PREDICTOR; CD133; EXPRESSION; SURVIVAL; OVEREXPRESSION; PROGRESSION; CARCINOMA; PATHWAY; MARKER;
D O I
10.3892/ol.2023.14153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The programmed death receptor 1/programmed death receptor ligand 1 axis (PD-1/PD-L1) is involved in tumor immune escape and is a potential prognostic biomarker and anti-tumor immunotherapy target in patients with gastric cancer (GC). However, the results of studies obtained in recent years have been inconsistent. The present study aimed to determine the possible predictive significance of PD-L1 in conjunction with three proteins linked with PD-L1 regulation in patients with primary GC. In the present study, the PD-L1, human epidermal growth factor receptor 2 (HER2), cluster of differentiation (CD)133 and microphage-associated CD68 expression levels were identified by multiplexed immunohistochemistry and assessed by automated pathological analysis system in 93 GC tumors and neighboring normal tissues arrayed on the same tissue microarray. All four proteins were statistically analyzed in relation to the clinicopathological characteristics. The expression levels of HER2, CD133 and CD68 were considerably higher in cancer tissues compared with neighboring normal tissues (P<0.05), however, the reverse trend was detected for PD-L1 expression (P=0.0577), particularly in tumor nest (TN; P<0.05). There was no significant correlation between the HER2 and CD133 expression levels and clinicopathological factors. However, significant relationships were found between PD-L1 expression and the TNM stage, pathological differentiation and survival status of patients (P<0.05). Moreover, survival time was prolonged in individuals with elevated PD-L1 expression in TN and GC tissues, but no significant correlation was identified (P=0.0881). The CD68 expression level in tumor stroma, but not in TN, was significantly correlated with poor pathological differentiation in patients with GC (P<0.05). However, PD-L1+CD68+ macrophages were strongly related to lower tumor size (diameter <5 cm), early TNM stage (stage I+II), good pathological differentiation and overall survival in TN (P<0.05). In conclusion, PD-L1+CD68+ macrophage infiltration in TN might be a potential indicator of prognosis in patients with primary GC and merits further investigation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PROGNOSTIC VALUE OF PD-L1 EXPRESSION AND CD68 MACROPHAGES IN TUMOR NEST OF PRIMARY GASTRIC CANCER PATIENTS
    Zou, Yunlian
    Tang, Hui
    GASTROENTEROLOGY, 2023, 164 (06) : S1192 - S1192
  • [2] CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1 expression in breast phyllodes tumor
    Shin, Eunah
    Kim, Hye Min
    Koo, Ja Seung
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (02) : 261 - 273
  • [3] Prognostic value of PD-L1 expression in patients with primary solid tumors
    Xiang, Xiao
    Yu, Peng-Cheng
    Long, Di
    Liao, Xiao-Li
    Zhang, Sen
    You, Xue-Mei
    Zhong, Jian-Hong
    Li, Le-Qun
    ONCOTARGET, 2018, 9 (04) : 5058 - 5072
  • [4] The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
    Chen, Li
    Zhao, Ruihu
    Sun, Hao
    Huang, Rong
    Pan, Hongming
    Zuo, Yanjiao
    Zhang, Lele
    Xue, Yingwei
    Li, Xingrui
    Song, Hongjiang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer
    Matveev, V. B.
    Kirichek, A. A.
    Safronova, V. M.
    Kokosadze, N., V
    Khalmurzaev, O. A.
    Kamolov, B. Sh
    Liubchenko, L. N.
    ONKOUROLOGIYA, 2019, 15 (01): : 57 - 65
  • [6] Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis
    Chen, Xiao-Jiang
    Wei, Cheng-Zhi
    Lin, Jun
    Zhang, Ruo-Peng
    Chen, Guo-Ming
    Li, Yuan-Fang
    Nie, Run-Cong
    Chen, Yong-Ming
    BIOMEDICINES, 2023, 11 (07)
  • [7] Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
    Shin, Kabsoo
    Kim, Joori
    Park, Se Jun
    Lee, Myung Ah
    Park, Jae Myung
    Choi, Myung-Gyu
    Kang, Donghoon
    Song, Kyo Young
    Lee, Han Hong
    Seo, Ho Seok
    Lee, Sung Hak
    Kim, Bohyun
    Kim, Okran
    Park, Juyeon
    Kang, Nahyeon
    Kim, In-Ho
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
    Kabsoo Shin
    Joori Kim
    Se Jun Park
    Myung Ah Lee
    Jae Myung Park
    Myung-Gyu Choi
    Donghoon Kang
    Kyo Young Song
    Han Hong Lee
    Ho Seok Seo
    Sung Hak Lee
    Bohyun Kim
    Okran Kim
    Juyeon Park
    Nahyeon Kang
    In-Ho Kim
    Scientific Reports, 13
  • [9] Characterization of PD-L1 expression and its prognostic value in patients with ovarian cancer
    Cheng, Bi-Heng
    Liang, Hua
    Jiang, Tao
    Chen, Jian-Hua
    Wang, Gao-Hua
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (05) : 1271 - 1281
  • [10] Prognostic value of PD-L1 expression in male breast cancer
    Abdeljaoued, Syrine
    Bettaieb, Ilhem
    Adouni, Olfa
    Goucha, Aida
    Chiba, Dorra
    Bouzaiene, Hatem
    Ben Hassouna, Jamel
    Boussen, Hamouda
    Rahal, Khaled
    Gamoudi, Amor
    CANCER RESEARCH, 2018, 78 (04)